Hide filtersShow filters × Close Bryan, Garnier & Co successfully leads a follow-on offering with rights for Valtech Bryan, Garnier & Co successfully leads Novagali Pharma €22m IPO Bryan, Garnier & Co leads a Eur 152m capital increase for Transgene Bryan, Garnier & Co successfully leads €6.7 million IPO for Integragen Equity Issue SparebankenVest AS Bryan, Garnier & Co leads a € 15,6 m capital increase for ExonHit Therapeutics Bryan, Garnier & Co has successfully advised majority shareholder GRED in the public tender offer & squeeze out of Softway Medical Bryan, Garnier & Co. announces it has advised ExonHit Therapeutics on the free allocation of subscription warrants to all its shareholders Bryan, Garnier & Co. announces successful admission of ONI BioPharma Inc.’s common stock to listing and trading on NYSE Alternext Paris Bryan, Garnier & Co successfully advised Pierrel on its EUR 17.1 million follow-on offering Bryan Garnier successfully leads €12 million IPO for Ipsogen Bryan, Garnier & Co successfully leads a €53.5 million follow-on offering for Risc Group
